Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 7, 2012; 18(21): 2661-2667
Published online Jun 7, 2012. doi: 10.3748/wjg.v18.i21.2661
Published online Jun 7, 2012. doi: 10.3748/wjg.v18.i21.2661
Totaln = 2242 | FHx (-)n = 2077 (92.6%) | FHx (+)n = 165 (7.4%) | P value | ||
Gender | Male | 1765 (78.7) | 1639 (78.9) | 126 (76.4) | 0.441 |
Female | 477 (21.3) | 438 (21.1) | 39 (23.6) | ||
Age | Median (min-max) | 57.0 (18.0-89.0) | 57.0 (18.0-89.0) | 52.0 (29.0-79.0) | < 0.0001 |
< 20 | 1 (0.1) | 1 (0.1) | 0 (0.0) | < 0.001 | |
20-29 | 13 (0.5) | 12 (0.6) | 1 (0.6) | ||
30-39 | 112 (5.0) | 99 (4.8) | 13 (7.9) | ||
40-49 | 458 (20.4) | 410 (19.7) | 48 (29.1) | ||
50-59 | 722 (32.2) | 661 (31.8) | 61 (37.0) | ||
60-69 | 640 (28.6) | 606 (29.2) | 34 (20.6) | ||
70-79 | 256 (11.4) | 248 (11.9) | 8 (4.8) | ||
≥ 80 | 40 (1.8) | 40 (1.9) | 0 (0.0) | ||
Etiology | HBV | 1683 (75.1) | 1548 (74.5) | 135 (81.8) | 0.236 |
HCV | 296 (13.2) | 280 (13.5) | 16 (9.6) | ||
Alcohol | 70 (3.1) | 68 (3.3) | 2 (1.2) | ||
Combined | 32 (1.4) | 31 (1.5) | 1 (0.6) | ||
Others | 50 (2.2) | 45 (2.2) | 5 (3.0) | ||
Unknown | 111 (5.0) | 105 (5.0) | 6 (3.6) | ||
HBV | HBV (+) | 1713 (76.4) | 1577 (75.9) | 136 (82.4) | 0.058 |
HBV (-) | 529 (23.6) | 500 (24.1) | 29 (17.6) | ||
HCV | HCV (+) | 315 (14.1) | 298 (14.3) | 17 (10.3) | 0.15 |
HCV (-) | 1927 (85.9) | 1779 (86.7) | 148 (89.6) | ||
Stage | I | 185 (8.3) | 167 (8.0) | 18 (10.9) | 0.221 |
II | 655 (29.2) | 602 (29.0) | 54 (32.7) | ||
III | 648 (28.9) | 610 (29.4) | 38 (23.1) | ||
IVa and IVb | 753 (33.6) | 698 (33.6) | 55 (33.3) | ||
Lab, | ALT (U/L) | 47.0 (3.0-3505.0) | 47.0 (3.0-3505.0) | 47.5 (3.0-840.0) | 0.987 |
median (min-max) | TB (mg/mL) | 1.1 (0.1-47.6) | 1.1 (0.1-47.6) | 1 (0.1-26.0) | 0.868 |
Alb (g/dL) | 3.5 (1.2-9.6) | 3.5 (1.2-9.6) | 3.7 (1.6-5.0) | 0.106 | |
Platelet (x 103/μL) | 121.5 (8.0-1084.0) | 121.0 (18.0-1084.0) | 133.0 (8.0-635.0) | 0.181 | |
Tumor markers, | AFP (ng/ mL) | 69.1 (0.0-529 470.0) | 67.00 (0.0-529 470.0) | 110.8 (1.1-53 606.0) | 0.972 |
median (min-max) | PIVKA-II (Mau/mL) | 88.0 (1.0-16 636.8) | 92.0 (1.0-16 636.8) | 80.0 (6.0-2000.0) | 0.990 |
- Citation: Park CH, Jeong SH, Yim HW, Kim JD, Bae SH, Choi JY, Yoon SK. Family history influences the early onset of hepatocellular carcinoma. World J Gastroenterol 2012; 18(21): 2661-2667
- URL: https://www.wjgnet.com/1007-9327/full/v18/i21/2661.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i21.2661